Dr Dale Garsed
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
92 Scholarly works
9 Projects
HIGHLIGHTS
2026
Journal article
IdentifiHR predicts homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression
DOI: 10.1038/s43856-026-01387-y2026
Journal article
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
DOI: 10.1038/s41467-026-71134-32026
Research grants (ARC, NHMRC, MRFF)
Driving Cancer Discoveries Through Integration of ‘Omics and Clinical Data
2024
Research grants (ARC, NHMRC, MRFF)
Harnessing the Immune Response in Exceptionally Long-Term Survivors of Ovarian Cancer to Develop Novel Therapeutics
2020
Research Grant
Understanding Adverse and Exceptional Outcomes in Ovarian Cancer
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature144102014
Journal article
The Architecture and Evolution of Cancer Neochromosomes
DOI: 10.1016/j.ccell.2014.09.010
RECENT SCHOLARLY WORKS
2026
Journal article
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.
DOI: 10.1158/1055-9965.EPI-25-18822026
Journal article
16P Integrative proteogenomics reveals survival-linked co-expression modules and an HR activity signature in high-grade serous ovarian cancer
DOI: 10.1016/j.esmoop.2026.1080412026
Journal article
Rethinking ovarian cancer III: the past decade and future directions
DOI: 10.1038/s41568-026-00916-02026
Journal article
Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS)
DOI: 10.1016/j.ijgc.2025.1030762026
Other
Supplementary Figure S1 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068692026
Other
Supplementary Figure S2 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068662026
Other
Supplementary Figure S5 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.310068542026
Other
Supplementary Figure S4 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
DOI: 10.1158/1078-0432.31006857